Therefore, the purpose of our current study was to identify the relationship between imaging features on US, RS, and the results of the Oncotype DX gene-expression assay in patients with ER-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.